Drug-induced cutaneous vasculitis developing during Etanercept treatment for rheumatoid arthritis
Biological disease-modifying anti-rheumatic drugs (bDMARDs) are widely used for the treatment of chronic inflammatory rheumatic diseases. Since the introduction of tumor necrosis factor alpha (TNF-) inhibitors, the treatment of rheumatoid arthritis has been revolutionized. The approach of targeting...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | RU |
| Publié: |
State Scientific Center of Dermatovenereology and Cosmetology
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/91175d6222fa48c88b9edfe7b48b771d |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Soyez le premier à ajouter un commentaire!